Find Academic Supervisors

Alexander T. Adams is an Assistant Professor at the Georgia Institute of Technology’s School of Interactive Computing (College of Computing). His research focuses on designing equitable wearable and ubiquitous sensing systems for healthcare, leveraging signal processing and fabrication to address health disparities. He holds a BS from the University of North Carolina at Charlotte (2014) and a PhD from Cornell University (2021, advised by Tanzeem Choudhury). Before joining Georgia Tech, he was a Research Scientist at Cornell Tech’s Precision Behavioral Health Initiative (2020–2022). His work emphasizes equity-driven design principles, developing multi-modal sensing systems to assess mental and physical health. Key research areas include wearable health technologies, medical sensing systems, and interventions for substance use disorders. Recent projects involve smartphone-based diagnostic tools (e.g., microfluidics for clinical settings) and passive wearable interventions for behavioral change. Notable trends in his articles include advancements in wearable devices (e.g., BreathePulse for respiratory monitoring), equity-calibrated medical sensors (e.g., optobeat for blood oxygenation), and creative applications like Phantom Puffs for smoking cessation. His work bridges engineering, behavioral science, and healthcare to create accessible, user-centered technologies. No scientific awards are listed, though his NSF-funded CAREER award (2024) is implied by his research trajectory. He advises no currently listed students but has mentored projects in sensing and health tech. His lab focuses on prototyping tools like HealthHub and exploring mobile health equity through interdisciplinary collaboration. Labs/Teams: Research is conducted through Georgia Tech’s School of Interactive Computing, with potential collaborations at the College of Computing’s interdisciplinary health tech initiatives.

• Ubiquitous Computing
• Novel Sensing and Feedback Systems
• Medical/Health Technology
• +1 more

Joe Kable, PhD, serves as the Baird Term Associate Professor of Psychology at the University of Pennsylvania, where his research investigates the neurophysiological basis of human decision-making through integrative approaches from experimental economics, cognitive neuroscience, and judgment psychology. His laboratory specializes in fMRI studies examining how subjective value representations guide choices involving immediate versus delayed rewards. Education: B.S. in Chemistry, Emory University PhD in Neuroscience, University of Pennsylvania Dr. Kable's research program centers on neural mechanisms of temporal discounting, risk assessment, and individual differences in choice behavior. His work demonstrates how socioeconomic status, aging, and clinical conditions modulate decision processes, with particular emphasis on hippocampal-prefrontal interactions during value computation. Recent studies reveal how time perception alterations affect neural activity in reward circuits and how social factors influence trust decisions across the lifespan. Analysis of his 15 most recent publications shows a strong methodological focus on fMRI and lesion studies, with growing clinical translation in depression, addiction, and dementia. Key thematic trends include the neural encoding of effort costs in social contexts, structural brain markers for impulsivity, and the dissociable roles of frontal subregions in persistence behaviors. His work consistently bridges basic decision neuroscience with real-world applications in mental health. Scientific Awards: No scientific awards mentioned in source material Dr. Kable leads an active research laboratory at Penn but the source text provides no details about graduate student advising or specific grant funding. His publications indicate collaboration with clinical researchers at the Penn Memory Center, particularly in aging-related decision studies. The laboratory employs multimodal neuroimaging techniques including resting-state fMRI, TMS, and lesion mapping to investigate decision circuits, with recent work extending to computational modeling of value representation and social cognition mechanisms.

• Decision Making
• Neuroeconomics
• Cognitive Neuroscience
• +2 more

Cecilie Schou Andreassen is a Professor at the Department of Clinical Psychology, University of Bergen . She specializes in behavioral addictions , including workaholism, social media addiction, and substance use interactions. Email: cecilie.andreassen@uib.no Visitor Address: Alrek Health Cluster, Årstadveien 17, 5009 Bergen Research Focus: Andreassen's work examines the psychosocial antecedents of addictive behaviors, with emphasis on personality traits , workplace dynamics , and digital platform interactions . Her research spans cross-cultural validation studies and longitudinal health outcomes related to technology and substance misuse. Article Trends (2017-2022): Analyzing 15 recent publications reveals a consistent focus on addiction scale validation , social media epidemiology , and workaholism's health impacts . Key themes include measurement invariance , digital-chemical addiction comorbidity , and psychological withdrawal mechanisms . Scientific Contributions: Co-developer of Bergen Work Addiction Scale Creator of Bergen-Yale Sex Addiction Scale Leadership in behavioral addiction epidemiology Recipient of Norwegian Research Council grants Advising & Collaborations: While no direct advisees are listed, Andreassen collaborates extensively with international researchers in work psychology , social media studies , and public health . Her work involves partnerships with Nottingham Trent University , Yale University , and National Competence Service for Sleep Disorders . Labs & Teams: Affiliated with the Department of Clinical Psychology and previously with the Department of Social Psychology at University of Bergen, she contributes to national health registry studies and cross-occupational research on addiction patterns.

• Behavioral Addictions
• Social Media Psychology
• Workaholism
• +3 more

Avinash V. Ramprashad serves as an Assistant Professor in the Department of Psychiatry at the University of Maryland School of Medicine, with clinical practice based at the University of Maryland Treatment Center. His educational background includes: Bachelor of Arts in Psychology from New York University (2011) Doctor of Medicine from SUNY Upstate Medical University COM, Syracuse, NY (2016) General Psychiatry Residency at University of Maryland/Sheppard Pratt (2020) Addiction Psychiatry Fellowship at University of Maryland (2021) Washington Baltimore Center for Psychoanalysis Fellowship Program (2020) Dr. Ramprashad specializes in addiction psychiatry with deep expertise in substance use disorders and evidence-based treatments including buprenorphine and methadone management. His clinical work integrates psychodynamic psychotherapy with innovative telemedicine applications, particularly in tele-addictions and tele-buprenorphine services, expanding access to care for underserved populations. He actively contributes to medical education and psychotherapy research within academic psychiatry. His professional recognition includes: George Balis Award for Excellence in Medical Student Education (2018) Dr. Donald Ross Award for Outstanding Psychotherapy Paper (2020) As a member of the Maryland Addiction Consultation Service (MACS), he participates in statewide initiatives providing expert consultation on complex addiction cases while advancing telehealth implementation in psychiatric practice.

• Addiction Psychiatry
• Substance Use Disorders
• Opioid Use Disorder Treatment
• +4 more

Professor Nicholas Buckley is a leading academic in Clinical Pharmacology at the University of Sydney and holds a Visiting Professor position at the University of Peradeniya, Sri Lanka. He serves as Research Director for the South Asian Clinical Toxicology Research Collaboration (SACTRC) and is a Consultant Clinical Pharmacologist & Toxicologist at the NSW Poisons Information Centre and Royal Prince Alfred Hospital. His work focuses on improving clinical toxicology practices, poison control policies, and understanding mechanisms of drug toxicity. Co-founder of SACTRC for agrochemical poisoning and snakebite research Chair of Australian Therapeutic Guidelines - Toxicology writing group Editorial roles in Clinical Toxicology, Drug Safety, and Australian Prescriber Research Interests include toxicovigilance, epidemiology of poisoning, acute kidney injury in poisoning/snakebite, pesticide safety interventions, antidote development, and pharmacoepidemiology of psychotropic drugs. His work combines clinical trials, population surveillance, and translational research. Scientific Contributions span 440+ peer-reviewed articles and 22 book chapters, with continuous funding since 2002. He has supervised over 20 higher degree students and leads international collaborations in low-and-middle-income countries through NIHR RIGHT4. Key Affiliations : Member of Charles Perkins Centre, Australian Medicines Handbook Editorial Advisory Board, and NIHR RIGHT4 programme.

• Clinical Toxicology
• Pharmacoepidemiology
• Poisoning
• +3 more

Kora DeBeck is a Distinguished Professor of Substance Use and Drug Policy in the School of Public Policy at Simon Fraser University, a CIHR Applied Public Health Chair, and Dorothy Killam Fellow. She is also a Research Scientist with the BC Centre on Substance Use and Principal Investigator of the At-Risk Youth Study (ARYS), a longitudinal cohort tracking over 1,200 street-involved youth. Her research focuses on substance use policy, health services for marginalized populations, and the structural drivers of drug-related harms. She has published over 200 peer-reviewed articles challenging ineffective drug enforcement models and advocating for policy reforms. Recent publications analyze trends in opioid use, harm reduction during the COVID-19 pandemic, drug decriminalization, and youth-focused interventions. Her work consistently addresses social inequities through data-driven approaches to the toxic drug crisis. CIHR Applied Public Health Chair Dorothy Killam Fellow Michael Smith Health Research BC Scholar Award Distinguished SFU Professorship She has secured over $50 million in research funding, including $21M as principal investigator for ARYS. Her lab collaborates with healthcare providers, community organizations, and policymakers to translate research into practice.

• Substance Use
• Drug Policy
• Health Policy
• +3 more

Jonathan H. Cantor is a Policy Researcher and Professor of Policy Analysis at the RAND School of Public Policy . His research focuses on health policies related to substance use disorder , mental health , and health behaviors , integrating frameworks from health economics , policy analysis , and public health . He leads the Mental Health and Addiction Treatment Tracking Repository , a national longitudinal database for substance use and mental health treatment facilities. His work examines treatment availability for older adults (funded by the National Institute on Aging) and telehealth services in mental health (funded by the National Institute of Mental Health). Recent NIMH grants aim to quantify mental health crisis services supply and its impact on population health. His recent publications (e.g., JAMA , Health Affairs ) address topics like opioid treatment accessibility , telehealth disparities , and food insecurity in higher education . His research spans health equity , preventive healthcare , and modeling/simulation approaches.

• Substance Use Disorder
• Mental Health
• Health Behaviors
• +10 more

Ashli Owen-Smith is a behavioral scientist affiliated with the School of Public Health at Georgia State University , where her research focuses on mental health disparities, suicide prevention, and integrative/complementary approaches for complex mental-physical health conditions. She works with underserved populations including refugees/immigrants, incarcerated individuals, and LGBTQ+ communities through community-based participatory research and mixed-methods frameworks. Her current projects are funded by CDC , DBHDD , and DPH . Education: Ph.D. in Behavioral Sciences (Emory, 2009), S.M. in Public Health (Harvard, 2005), B.A. in Psychology (Smith College, 2001) Her research spans mental health , trauma , suicide prevention , and mindfulness-based interventions . Recent work examines telehealth adaptations for chronic pain and mental health, vaccine hesitancy in refugee communities, and social determinants of suicide . She leads studies on gender-affirming care and health disparities in LGBTQ+ populations. Key article trends include epidemiological analysis of suicide risk factors, COVID-19 impacts on mental health, ICD-10 coding for autism, and complementary medicine in trauma recovery. Subfields span telehealth , health equity , mental-physical comorbidity , and community engagement . Students she has mentored include C.A. Scarlett , T. Griner , and M.M. Sesay . Her work integrates public health policy , clinical research , and health systems analysis .

• Mental Health
• Behavioral Science
• Trauma
• +6 more

Tamar Rodney is an Assistant Professor at the Johns Hopkins University School of Nursing , specializing in psychiatric mental health. She serves as the DNP Advanced Practice Psych Mental Health Track Coordinator and is affiliated with the Center for Community Programs, Innovation, and Scholarship (COMPASS) and the Center for Infectious Disease and Nursing Innovation . Dr. Rodney’s research focuses on PTSD and traumatic brain injury (TBI) in military personnel and veterans. Her work explores biomarkers , inflammatory responses , and meaning theory to improve diagnosis and treatment planning for mental health conditions. She also investigates telehealth , dementia care , and social isolation in vulnerable populations. Recent publications highlight her expertise in PTSD prevalence among nurses, telehealth applications , biomarker analysis , and community-based interventions for cognitive impairments. Her work bridges neurobiology and psychiatric nursing to inform military health policy . 2022 Coeur de Catherine – St. Catherine University 2021 AMERSA Marianne Marcus Award Multiple scholarships/fellowships (2010–2022) Dr. Rodney’s clinical practice, research, and advocacy address substance use disorders , resilience , and global health challenges. She actively contributes to policy development and education in psychiatric nursing.

• Posttraumatic Stress Disorder (PTSD)
• Trauma-Informed Care
• Mental Health
• +9 more

Univ-Prof. Dr. med. Malek Bajbouj serves as Director of the Institute for Affective Neuroscience and Emotion Modulation at Charité – University Medicine Berlin's Campus Benjamin Franklin (CBF), operating within the Department of Neurology, Neurosurgery and Psychiatry (CC 15). His position integrates clinical leadership with translational neuroscience research focused on severe mental illnesses. Dr. Bajbouj's research program centers on affective neuroscience and emotion dysregulation mechanisms in psychiatric disorders, particularly schizophrenia spectrum conditions and depression. He pioneers multimodal intervention approaches combining neuromodulation (tDCS), oxytocin augmentation, mindfulness therapies, and digital health tools. His work emphasizes translational biomarker development using neuroimaging, machine learning, and physiological stress parameter analysis to personalize treatment for treatment-resistant populations. Analysis of his 2023-2025 publications reveals three dominant research trajectories: (1) novel treatment combinations for negative symptoms in schizophrenia (oxytocin + mindfulness, yoga therapy); (2) real-world implementation of neuromodulation (at-home tDCS protocols, technical efficacy monitoring); and (3) global mental health responses to crises (pandemic impacts on vulnerable groups, culturally adapted refugee interventions). His methodology consistently employs rigorous randomized controlled trials with embedded biomarker studies. As director of his eponymous institute, Dr. Bajbouj leads a multidisciplinary team conducting neuroimaging studies, clinical trials, and international collaborations focused on emotion modulation pathways. The institute coordinates research across CC 15's clinical infrastructure at CBF Building V, with particular emphasis on bridging laboratory neuroscience with clinical psychiatry through the DepressionDC and OXYMIND trial frameworks.

• Affective Neuroscience
• Emotion Regulation
• Schizophrenia Spectrum Disorders
• +4 more

Brian A. Primack is a Professor of Public Health with tenure at Oregon State University's College of Public Health and Human Sciences, serving as its dean since 2022. Previously, he was Dean of Education and Health Professions at the University of Arkansas and Dean of the Honors College at the University of Pittsburgh. His research focuses on social media's impact on mental health, including depression, anxiety, and loneliness. He has authored over 300 publications, including his book You Are What You Click , and secured over $10 million in federal research funding. Dr. Primack's research highlights both risks and opportunities of digital media. He emphasizes optimizing social media use through strategies like curating connections and mitigating negativity. His work intersects education, medicine, and public health, addressing disparities in health outcomes, such as those exacerbated during the pandemic. Notable awards include membership in the American Society of Clinical Investigation (2019) and the Next Big Idea Book Award shortlist (2021). His leadership philosophy prioritizes unlocking potential, fostering community trust, and advancing equitable health solutions. He oversees a college with nearly 2,400 students and $18 million in annual research funding, emphasizing community engagement and innovative scholarship.

• Social Media and Mental Health
• Public Health
• Behavioral Science
• +3 more

Aditi Das is a Full Professor in the School of Chemistry and Biochemistry at the Georgia Institute of Technology, College of Sciences. She leads the Das Laboratory, which focuses on the biochemistry and chemical biology of lipids, particularly studying cytochrome P450 enzymes and their role in lipid metabolism, endocannabinoid systems, and inflammatory pathways. Her educational background includes: B.Sc. in Chemistry from St. Stephen's College M.Sc. in Chemistry from Indian Institute of Technology, Kanpur (I.I.T) Ph.D. in Chemistry from Princeton University Postdoctoral research at Northwestern University (NSF-NSEC fellow) and Beckman Institute for Advanced Science and Technology, University of Illinois UC Professor Das's research interests center around understanding the physiological role of lipids in sustaining homeostasis and their implications in disease states such as neurodegenerative disorders, cancer, and cardiovascular diseases. Her laboratory specializes in: Enzymology of cytochrome P450s, particularly CYP2J2 epoxygenase Metabolism of ω-3 and ω-6 fatty acids and their derivatives Minor cannabinoid metabolism by cytochrome P450 enzymes Discovery of novel anti-inflammatory lipid metabolites and endocannabinoids Mechanistic studies of membrane proteins using nanodisc technology Her work bridges biochemistry, chemical biology, and pharmacology to uncover novel therapeutic targets related to lipid signaling pathways. Analysis of Professor Das's recent publications (2023-2025) reveals a strong focus on cannabinoid metabolism by cytochrome P450 enzymes, with particular emphasis on how these metabolic processes generate bioactive compounds that interact with the endocannabinoid system. Her research increasingly explores the therapeutic potential of omega-3 derived endocannabinoid epoxides in inflammatory and neurodegenerative conditions. The use of nanodisc technology for studying membrane proteins in near-native environments remains a consistent methodological thread throughout her work, enabling detailed mechanistic insights into enzyme function. Professor Das has received numerous prestigious awards recognizing her research excellence and teaching: 2024 NIH Outstanding Researcher Award (MIRA R35) for established investigators 2024 Vasser Woolley Faculty Fellowship 2023 Plenary Lecture at the International Society of the Study of Xenobiotics (ISSX) 2021 E.L.R. Stokstad Award 2019-2021 List of Teachers Ranked as Excellent 2019 Eicosanoid Research Foundation Young Investigator Award 2019 Zoetis Research Excellence Award 2019 Mary Swartz Rose Young Investigator Award 2015 National Scientist Development Award from the American Heart Association 2022 El Sohly Award from the American Chemical Society Professor Das actively mentors a diverse group of students and postdoctoral researchers, with several former lab members now holding faculty positions or working at prestigious institutions. Her laboratory has secured significant funding from NIH, NSF, and other sources to support research on lipid metabolism, cannabinoid pharmacology, and membrane protein biochemistry. Notable grants include an NIH R35 Outstanding Investigator Award (MIRA), an NIH R21 grant from NIDA, and multiple collaborative grants with other research groups. The Das Laboratory operates within the Petit Institute of Bioengineering and Biosciences (IBB) at Georgia Tech, utilizing state-of-the-art facilities for biochemical and biophysical studies. The lab specializes in nanodisc technology to study membrane proteins in near-native environments, with particular expertise in cytochrome P450 enzymes and their interactions with lipid substrates. Recent work has expanded into collaborative projects involving lipidomics, structural biology, and translational applications of lipid signaling research.

• Biochemistry and Chemical biology of Lipids
• Mechanism of Membrane proteins in Nanodiscs
• Enzymology of metalloproteins
• +5 more

Laura Robinson is a Senior Lecturer at the School of Psychology , University of Wollongong. She holds a Doctor of Philosophy in Psychology and extensive teaching experience in behavioral sciences, statistics, and applied psychology. Education : PhD in Psychology (2017), Postgraduate Diploma in Psychology (2010), Bachelor of Psychology (2009), and Bachelor of Aviation (2004) Her research focuses on vulnerable populations, particularly women and youth, with expertise in substance use disorders, eating disorders, mental health comorbidity, and health equity. She has published extensively on residential treatment outcomes, continuing care interventions, and stigma reduction in mental healthcare. Recent publications highlight longitudinal analyses of psychological distress, weight stigma, and integrated approaches to substance use and physical health. She supervises PhD students on topics like veterans' mental health, methamphetamine use, and suicide prevention. Laura has received funding from internal and external sources, including grants for stimulant use interventions and health literacy studies. She serves on committees like the Australasian Professional Society for Alcohol and Drugs and contributes to peer-reviewed journals as a reviewer.

• Clinical Psychology
• Health Psychology
• Substance Use Disorders
• +9 more

Nick Bansback is an Honorary Visiting Professor in the School of Population and Public Health at the University of British Columbia (primary affiliation) and affiliated with NUS Saw Swee Hock School of Public Health. His research focuses on maximizing healthcare value through economic evaluation, patient preference measurement, and decision analysis. He holds a PhD in Health Economics and Decision Sciences (University of Sheffield, 2010), an MSc in Health Economics (2004), and a BSc in Mathematics (2001). Key research areas include health technology assessment, patient-reported outcomes, and cost-effectiveness analysis of treatments for chronic conditions like rheumatoid arthritis and multiple sclerosis. He has pioneered methods for incorporating patient preferences into healthcare decisions, including developing decision aids and discrete-choice experiments. His work has been recognized with awards such as the UBC Killam Research Award (2020) and the Canadian Agency for Drugs and Technology in Health Rising Star Award (2016). He has contributed to over 30 peer-reviewed publications, emphasizing practical applications of health economics to improve healthcare resource allocation and patient-centered care. Prof. Bansback’s career spans postdoctoral research at UBC, health economics roles at the Centre for Health Evaluation and Outcomes Sciences, and early research at the University of Sheffield. His interdisciplinary approach bridges clinical practice, policy, and quantitative methods to address complex healthcare challenges.

• Health Economics
• Decision Analysis
• Health Technology Assessment
• +5 more

Tim Woodman is a Professor in Sport & Exercise at the School of Psychology and Sport Science , Bangor University. He is a leading expert in Performance Psychology , focusing on personality, stress, anxiety, and risk-taking in elite sports. His groundbreaking theory positions risk as central to human development and performance. Research Interests : Narcissism, anxiety-performance relationships, risk-taking behavior, athlete mental health, agentic emotion regulation. Scientific Contributions : Over 150 peer-reviewed publications, including 2025 studies on cricket mental health, coach support dynamics, and pressure training methodologies in elite sports. Projects : Leads the North West Air Ambulance performance psychology initiative and collaborates with Manchester City Football Club on personality-climate change research. Teaching & Supervision : Accepts PhD students interested in risk-taking, personality, and performance psychology topics.

• Performance Psychology
• Risk-Taking Behavior
• Personality
• +3 more